Evidence map›Paper›PMID 25574463›Full record

ArticleJournal of cancer prevention2014

Anti-inflammatory Effects of Schisandra chinensis (Turcz.) Baill Fruit Through the Inactivation of Nuclear Factor-κB and Mitogen-activated Protein Kinases Signaling Pathways in Lipopolysaccharide-stimulated Murine Macrophages.

Young-Soon Kang, Min-Ho Han, Su-Hyun Hong, Cheol Park, Hye-Jin Hwang, Byung Woo Kim, Kim Ho Kyoung, Young Whan Choi, Cheol Min Kim, Yung Hyun Choi

Open access · greenAbstract read
In one paragraph

Article in Journal of cancer prevention, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
1.4field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 38 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Anti-Aging Effects ofEvidence-based complementary and alternative medicine : eCAM · 2019
    Article
  11. Article
  12. Article
  13. Article
  14. Evidence-based complementary and alternative medicine : eCAM · 2017
    Article
  15. Article
  16. Article
  17. Pharmacokinetic and bioavailability study of angeloylgomisin H in rat plasma by UPLC-MS/MS.International journal of clinical and experimental medicine · 2015
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 2 countries.

Young-Soon KangDepartment of Biochemistry, Dongeui University College of Korean Medicine, Busan, Korea.
Min-Ho HanDepartment of Biochemistry, Dongeui University College of Korean Medicine, Busan, Korea.
Su-Hyun HongDepartment of Biochemistry, Dongeui University College of Korean Medicine, Busan, Korea.
Cheol ParkDepartment of Molecular Biology, College of Natural Sciences and Human Ecology, Dongeui University, Busan, Korea.
Hye-Jin HwangBlue-Bio Industry RIC and Anti-Aging Research Center, College of Natural Sciences and Human Ecology, Dongeui University, Busan, Korea ; Department of Food and Nutrition, College of Natural Sciences and Human Ecology, Dongeui University, Busan, Korea.
Byung Woo KimBlue-Bio Industry RIC and Anti-Aging Research Center, College of Natural Sciences and Human Ecology, Dongeui University, Busan, Korea ; Department of Life Science and Biotechnology, College of Natural Sciences and Human Ecology, Dongeui University, Busan, Korea.
Kim Ho KyoungHerbal Medicine Resources Group, Herbal Medicine Research Division, Korea Institute of Oriental Medicine, Daejeon, Korea.
Young Whan ChoiDepartment of Horticultural Bioscience and Life and Industry Convergence Research Institute, College of Natural Resource and Life Sciences, Pusan National University, Miryang, Korea.
Cheol Min KimDepartment of Biochemistry, Pusan National University School of Medicine, Yangsan, Korea.
Yung Hyun ChoiDepartment of Biochemistry, Dongeui University College of Korean Medicine, Busan, Korea ; Blue-Bio Industry RIC and Anti-Aging Research Center, College of Natural Sciences and Human Ecology, Dongeui University, Busan, Korea.
Dong-Eui University · KRFood and Nutrition Service · USKorea Institute of Oriental Medicine · KRPusan National University · KR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundSchisandrae Fructus, the dried fruit of Schisandra chinensis (Turcz.) Baill. (Magnoliaceae), is widely used in traditional medicine for the treatment of a number of chronic inflammatory diseases. This study examined the anti-inflammatory effects of Schisandrae Fructus ethanol extract (SF) on the production of pro-inflammatory substances in lipopolysaccharide (LPS)-stimulated RAW 264.7 macrophages.

methodsTo measure the effects of SF on pro-inflammatory mediator and inflammatory cytokine's expression and production in RAW 264.7 cells, we used the following methods: cell viability assay, Griess reagent assay, enzyme-linked immunosorbent assay, reverse transcriptase-polymerase chain reaction, Western blotting analysis and immunofluorescence staining.

resultsStimulation of the RAW 264.7 cells with LPS caused an elevated production of nitric oxide (NO), tumor necrosis factor α (TNF-α) and interleukin (IL)-1β, which was markedly inhibited by the pretreatment with SF without causing any cytotoxic effects. SF also inhibited the expression of inducible NO synthase, TNF-α, and IL-1β protein and their mRNAs in LPS-stimulated RAW 264.7 cells. Furthermore, SF attenuated LPS-induced nuclear translocation of nuclear factor-κB (NF-κB) by reducing inhibitory-κB degradation, and reduced the phosphorylation of mitogen-activated protein kinases (MAPKs), implying that SF regulated LPS-induced NF-κB-dependent inflammatory pathways through suppression of MAPKs activation.

conclusionsSF may be useful for the treatment of various inflammatory diseases.

Indexed as

Anti-inflammationMitogen-activated protein kinasesNuclear factor-kappa BSchisandra chinensis

Identifiers

PMID25574463
PMCPMC4285959
OpenAlexW1984741439

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.